The sticky, contracted engine — CPG laminates & pouches, Asepto aseptic packs, holography & security and specialty / PCR films programs; the ₹5,069 Cr book (+18%), the renewals at risk, and the dispatch & quality behind the promise.
₹310 Cr of the ₹2,380 Cr contract renewal wall is flagged at-risk against a ₹5,069 Cr Value-Added & Converting book (+18.0% FY26) retaining at 104% NRR. Defend the at-risk slice and attach the next line (films ↔ converting ↔ aseptic) into named CPG accounts — value-added mix 33% → 40% is the number the market pays for.
5 of 6 headline metrics improving vs prior · still off target: Value-Added & Converting Mix 33.0% vs 40.0%, CPG Account Net Revenue Retention 104.0% vs 108.0%, Aseptic Packs Sold (Asepto) 7.97 bn vs 12
Each point of attrition on the ₹5,069 Cr base is ₹51 Cr of value-added revenue gone — the sticky CPG-contract book is what offsets the commodity-films cycle; far cheaper to retain than to re-win.
Each lost contract is value-added & converting revenue — the sticky book that carries the films cycle.
Each lost contract is value-added & converting revenue — the sticky book that carries the films cycle.
Value-added mix 33% sits 7pts below the 40% target; Aseptic (Asepto) packs is the best economics in the book at 47% GM and 111% retention — and Egypt doubles its capacity to 24 bn packs.
Value-Added & Converting revenue is UFlex's sticky engine against the commodity-films cycle — ₹5,069 Cr across 430 active contracts, +18.0% FY26, retaining at 104%. This view is where it's defended: which product lines carry the margin, which contracts are up for renewal and at risk, and whether delivery quality is holding up the promise.
Aseptic (Asepto) packs is the highest-margin, highest-retention line — the one to attach across CPG accounts. Asepto revenue is MODELED (~₹1,300 Cr from packs × realization; not separately disclosed).
Next four quarters of CPG contract renewals. At-risk = attrition-flagged or contraction-likely.
Defend first: the ₹310 Cr at-risk slice. Each point of attrition on the ₹5,069 Cr base is ₹51 Cr of value-added revenue gone — far cheaper to retain than to re-win, and it's the earnings quality the re-rating case leans on.
Value-added mix is 33% vs a 40% target; the gap is converting & aseptic content not yet attached to accounts already buying films.
Aseptic (Asepto) packs is the lever: 47% GM and 111% NRR — the best economics in the book. Attaching it to CPG accounts already buying laminates or films lifts both margin and mix (Sanand runs 12 bn packs; Egypt doubles it to 24 bn).
Flexible packaging (laminates & pouches) is the moat: 240 sticky contracts — CPG spec- and artwork-locked; the foot in the door for cross-line attach.
Contracts only renew if delivery is good — these are the dispatch, quality & utilization measures behind the book.